Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Itakura

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Journal of Medical Virology|September 5, 2020
Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis CMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology|May 31, 2021
Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patientsShun Kaneko, Masayuki Kurosaki, Kento Inada, et al.
Liver Cancer|October 27, 2016
Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib TreatmentHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 7, 2008
[Epithelioid hemangioendothelioma of the liver diagnosed by laparoscopy guided biopsy]Nobutoshi Komatsu, Masayuki Kurosaki, Mitsuaki Sato, et al.
Journal of Gastroenterology|April 1, 2021
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitisJun Itakura, Masayuki Kurosaki, Hiroko Setoyama, et al.
Diabetes|February 4, 2011
RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetesKaoru Aida, Yoriko Nishida, Shoichiro Tanaka, et al.
Plos One|February 13, 2016
Pretreatment Gastric Lavage Reduces Postoperative Bleeding after Endoscopic Submucosal Dissection for Gastric NeoplasmsHiroyuki Nakanishi, Masayuki Kurosaki, Yuka Takahashi, et al.
Plos One|February 16, 2019
Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive proceduresHitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Journal of Viral Hepatitis|January 23, 2021
Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatmentSakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Gastroenterology|May 13, 2008
Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral responseYasuhiro Asahina, Namiki Izumi, Itsuko Hirayama, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Journal of Medical Virology|September 5, 2020
Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis CMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology|May 31, 2021
Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patientsShun Kaneko, Masayuki Kurosaki, Kento Inada, et al.
Liver Cancer|October 27, 2016
Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib TreatmentHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 7, 2008
[Epithelioid hemangioendothelioma of the liver diagnosed by laparoscopy guided biopsy]Nobutoshi Komatsu, Masayuki Kurosaki, Mitsuaki Sato, et al.
Journal of Gastroenterology|April 1, 2021
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitisJun Itakura, Masayuki Kurosaki, Hiroko Setoyama, et al.
Diabetes|February 4, 2011
RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetesKaoru Aida, Yoriko Nishida, Shoichiro Tanaka, et al.
Plos One|February 13, 2016
Pretreatment Gastric Lavage Reduces Postoperative Bleeding after Endoscopic Submucosal Dissection for Gastric NeoplasmsHiroyuki Nakanishi, Masayuki Kurosaki, Yuka Takahashi, et al.
Plos One|February 16, 2019
Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive proceduresHitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Journal of Viral Hepatitis|January 23, 2021
Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatmentSakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Gastroenterology|May 13, 2008
Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral responseYasuhiro Asahina, Namiki Izumi, Itsuko Hirayama, et al.
Pageof 13